COST-EFFECTIVENESS OF INDIVIDUALIZING GLYCEMIC GOALS FOR US ADULTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Laiteerapong, Neda [1 ]
Cooper, Jennifer [1 ]
Naylor, Rochelle N. [1 ]
Huang, Elbert S. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S169 / S170
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF PULMONARY REHABILITATION IN US ADULTS WITH COPD
    Mosher, Christopher
    Nanna, Michael
    Jawitz, Oliver
    Raman, Vignesh
    Farrow, Norma
    Aleem, Samia
    MacIntyre, Neil
    Palmer, Scott
    Myers, Evan
    CHEST, 2020, 158 (04) : 2059A - 2060A
  • [42] Screening for proteinuria in US adults - A cost-effectiveness analysis
    Boulware, LE
    Jaar, BG
    Tarver-Carr, ME
    Brancati, FL
    Powe, NR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23): : 3101 - 3114
  • [43] Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US
    Lee, W. C.
    Conner, C.
    Hammer, M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (05) : 897 - 906
  • [44] The cost-effectiveness of adding rosiglitazone versus sulfonlurea to metformin in a US obese type 2 diabetes population
    Richter, A
    Thieda, P
    Bagust, A
    Perry, A
    DIABETES, 2003, 52 : A524 - A524
  • [45] The cost-effectiveness of treatment for Type I Diabetes
    Budhiarso, I
    Gonzalez-Vizoso, R
    Martin, ML
    Bushnell, DM
    Mingliang, Z
    VALUE IN HEALTH, 2003, 6 (06) : 798 - 798
  • [46] Cost-effectiveness of financial incentives to improve glycemic control in adults with diabetes: A pilot randomized controlled trial
    Egede, Leonard E.
    Walker, Rebekah J.
    Dismuke-Greer, Clara E.
    Pyzyk, Sarah
    Dawson, Aprill Z.
    Williams, Joni S.
    Campbell, Jennifer A.
    PLOS ONE, 2021, 16 (03):
  • [47] Cost-effectiveness and clinical outcomes of metformin or insulin add-on therapy in adults with type 2 diabetes
    Brown, RR
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 : S24 - S27
  • [48] The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
    Herman, WH
    Hoerger, TJ
    Brandle, M
    Hicks, K
    Sorensen, S
    Zhang, P
    Hamman, RF
    Ackermann, RT
    Engelgau, MM
    Ratner, RE
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 323 - 332
  • [49] Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes
    Hoerger, TJ
    Bethke, AD
    Richter, A
    Sorensen, SW
    Engelgau, M
    Thompson, T
    Narayan, KMV
    Williamson, DF
    Gregg, E
    Zhang, P
    Eastman, RC
    Fuller, J
    Gibbons, CB
    Haffner, S
    Herman, WH
    Howard, B
    Ratner, R
    Orchard, T
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19): : 2542 - 2551
  • [50] Intensive glycemic control in younger and older US adults with type 2 diabetes
    Casagrande, Sarah
    Cowie, Catherine C.
    Fradkin, Judith E.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (08) : 1299 - 1304
12345